These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1606538)

  • 21. Combining volume-weighted mean nuclear volume with Gleason score and clinical stage to predict more reliably disease outcome of patients with prostate cancer.
    Fujikawa K; Sasaki M; Itoh T; Arai Y; Ogawa O; Yoshida O
    Prostate; 1998 Oct; 37(2):63-9. PubMed ID: 9759699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume.
    Fujikawa K; Sasaki M; Arai Y; Yamabe H; Ogawa O; Yoshida O
    Clin Cancer Res; 1997 Apr; 3(4):613-8. PubMed ID: 9815728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models.
    Quinn DI; Henshall SM; Haynes AM; Brenner PC; Kooner R; Golovsky D; Mathews J; O'Neill GF; Turner JJ; Delprado W; Finlayson JF; Sutherland RL; Grygiel JJ; Stricker PD
    J Clin Oncol; 2001 Aug; 19(16):3692-705. PubMed ID: 11504751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression.
    Veltri RW; Partin AW; Epstein JE; Marley GM; Miller CM; Singer DS; Patton KP; Criley SR; Coffey DS
    J Cell Biochem Suppl; 1994; 19():249-58. PubMed ID: 7529856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
    J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy.
    Veltri RW; Isharwal S; Miller MC; Epstein JI; Partin AW
    Prostate; 2010 Sep; 70(12):1333-9. PubMed ID: 20623633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas.
    Vesalainen S; Lipponen P; Talja M; Kasurinen J; Syrjänen K
    Prostate; 1995 Aug; 27(2):110-7. PubMed ID: 7638083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
    Rubin MA; Mucci NR; Manley S; Sanda M; Cushenberry E; Strawderman M; Montie JE; Bassily NH
    J Urol; 2001 Jan; 165(1):114-8. PubMed ID: 11125378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
    Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
    Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
    Rogers CG; Khan MA; Craig Miller M; Veltri RW; Partin AW
    Cancer; 2004 Dec; 101(11):2549-56. PubMed ID: 15470681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.
    Cheng L; Koch MO; Juliar BE; Daggy JK; Foster RS; Bihrle R; Gardner TA
    J Clin Oncol; 2005 May; 23(13):2911-7. PubMed ID: 15860849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease.
    Reese AC; Cooperberg MR; Carroll PR
    J Urol; 2010 Jul; 184(1):114-9. PubMed ID: 20478578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.
    Perlis N; Sayyid R; Evans A; Van Der Kwast T; Toi A; Finelli A; Kulkarni G; Hamilton R; Zlotta AR; Trachtenberg J; Ghai S; Fleshner NE
    J Urol; 2017 Jan; 197(1):75-83. PubMed ID: 27457260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer.
    Waltregny D; Bellahcène A; Van Riet I; Fisher LW; Young M; Fernandez P; Dewé W; de Leval J; Castronovo V
    J Natl Cancer Inst; 1998 Jul; 90(13):1000-8. PubMed ID: 9665149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.
    Veltri RW; Isharwal S; Miller MC; Epstein JI; Mangold LA; Humphreys E; Partin AW
    Prostate; 2008 Dec; 68(16):1806-15. PubMed ID: 18767028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of nuclear shape in aspirated and histologic specimens of prostatic carcinoma.
    Tardif CP; Partin AW; Qaqish B; Epstein JP; Mohler JL
    Anal Quant Cytol Histol; 1992 Dec; 14(6):474-82. PubMed ID: 1292446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
    Thomas J; Gupta M; Grasso Y; Reddy CA; Heston WD; Zippe C; Dreicer R; Kupelian PA; Brainard J; Levin HS; Klein EA
    J Clin Oncol; 2002 Aug; 20(15):3213-8. PubMed ID: 12149293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.